Briefs

NEWARK, Del. (USA) - September 5, 2008 -- Miner3D, the visual data analytics innovations leader, today announced that RaQualia Pharma, Inc., will use Miner3D as its main R&D data analytics platform.

RaQualia, a pharmaceutical research and development company, is a spin off of drug maker giant Pfizer. The company focuses on pain and gastrointestinal therapeutic areas and manages six innovative drug discovery programs.

Miner3D helps RaQualia's scientists and researchers to better understand vast amounts of scientific data, improve leads identification and speed up research and development processes.

About Miner3D:
Miner3D is the leading innovator of data visualization and visual data mining software. We strive to deliver creative and easy-to-use business intelligence and scientific research software products. Powerful, yet affordable, Miner3D capabilities allow business and scientific users to easily spot trends, patterns, clusters, outliers or unexpected relationships in data.

For more information and for free evaluation software, please visit http://www.miner3D.com

Contact:
Miner3D, Inc.
+1 (302) 213-0121
info@miner3D.com
http://www.miner3D.com